Javascript must be enabled to continue!
Iron Overload Cardiomyopathy
View through CrossRef
Iron overload cardiomyopathy is a condition of excessive iron accumulation in cardiomyocytes due to abnormal iron absorption or repeated blood transfusion. In the early stages, the patient may be asymptomatic with good ventricular systolic function. Iron deposit in ventricular cause dyspnea on effort due to left ventricular systolic dysfunction then in atrial cause atrioventricular block and supraventricular arrhythmic. For severe symptom due to dilated cardiomyopathy is characterized by left ventricular dilatation and risk of sudden cardiac death. Diagnosis of iron overload cardiomyopathy can be made if there is evidence of heart disease, the presence of iron overload (serum ferritin > 300 ng/mL and transferrin saturation > 55%) and cardiac siderosis with cardiac MRI T2 * < 20 ms as gold standard. Patient management involves lowering systemic iron levels and preventing iron entry into cardiomyocytes. Therapy with phlebotomy or iron chelation as indicated. Administration of calcium channel blockers and resveratrol antioxidant therapy may be considered to reduce morbidity and mortality due to cardiac siderosis.
Title: Iron Overload Cardiomyopathy
Description:
Iron overload cardiomyopathy is a condition of excessive iron accumulation in cardiomyocytes due to abnormal iron absorption or repeated blood transfusion.
In the early stages, the patient may be asymptomatic with good ventricular systolic function.
Iron deposit in ventricular cause dyspnea on effort due to left ventricular systolic dysfunction then in atrial cause atrioventricular block and supraventricular arrhythmic.
For severe symptom due to dilated cardiomyopathy is characterized by left ventricular dilatation and risk of sudden cardiac death.
Diagnosis of iron overload cardiomyopathy can be made if there is evidence of heart disease, the presence of iron overload (serum ferritin > 300 ng/mL and transferrin saturation > 55%) and cardiac siderosis with cardiac MRI T2 * < 20 ms as gold standard.
Patient management involves lowering systemic iron levels and preventing iron entry into cardiomyocytes.
Therapy with phlebotomy or iron chelation as indicated.
Administration of calcium channel blockers and resveratrol antioxidant therapy may be considered to reduce morbidity and mortality due to cardiac siderosis.
Related Results
Iron stress affects the survival of Toxoplasma gondii
Iron stress affects the survival of Toxoplasma gondii
Abstract
Background
Iron possesses redox abilities and plays a crucial role in in biosynthesis, energy metabolism, and other biological processes. It represents an indispe...
Hetrombopag, an Emerging Iron-Chelating Agent, Alleviates Systemic Iron Overload
Hetrombopag, an Emerging Iron-Chelating Agent, Alleviates Systemic Iron Overload
Background: Iron overload is a syndrome in which excessive iron accumulates in the body, leading to tissue damage and functional disorders. This condition is common in patients wit...
Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation
Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation
Abstract
Abstract 347
Introduction:
Iron overload is frequent in patients undergoing allogeneic hematopoietic ste...
Iron Overload in Patients with Paroxysmal Nocturnal Hemoglobinuria
Iron Overload in Patients with Paroxysmal Nocturnal Hemoglobinuria
Abstract
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal bone marrow disorder caused by a somatic mutation in PIGA that leads to a marked...
Molecular and Cellular Determinants of Human Iron Overload Cardiomyopathy
Molecular and Cellular Determinants of Human Iron Overload Cardiomyopathy
Abstract
Iron overload cardiomyopathy (IOC) is a serious heart condition that is caused by elevated levels of systemic iron. IOC is characterized by both systolic a...
Clinical profiles and incident heart failure in cardiomyopathies: a population-based linked electronic health record cohort study
Clinical profiles and incident heart failure in cardiomyopathies: a population-based linked electronic health record cohort study
Abstract
Background
Cardiomyopathies frequently cause heart failure (HF), however their prevalence in the general population and...
Effect of Different Dietary Iron Contents on Liver Transcriptome Characteristics in Wujin Pigs
Effect of Different Dietary Iron Contents on Liver Transcriptome Characteristics in Wujin Pigs
Iron is an important trace element that affects the growth and development of animals and regulates oxygen transport, hematopoiesis, and hypoxia adaptations. Wujin pig has unique h...
Implications of Low Zinc and Copper Levels As Well As Altered Iron Trafficking Proteins on Oxidant Stress in Patients with Transfusion Dependant Thalassemia
Implications of Low Zinc and Copper Levels As Well As Altered Iron Trafficking Proteins on Oxidant Stress in Patients with Transfusion Dependant Thalassemia
Abstract
Introduction:Patients with transfusion dependent thalassemia (TDT) have a genetic anemia that causes incomplete erythropoiesis and iron overload. Plasma zin...

